110 related articles for article (PubMed ID: 10604932)
1. Effects of beta-adrenergic stimulation on the acutely obstructed ureter in dogs.
Murakami M; Tomiyama Y; Hayakawa K; Akahane M; Ajisawa Y; Park YC; Ohnishi N; Sugiyama T; Kurita T
J Pharmacol Exp Ther; 2000 Jan; 292(1):67-75. PubMed ID: 10604932
[TBL] [Abstract][Full Text] [Related]
2. Ureteral selectivity of intravenous β-adrenoceptor agonists in pig model of acute ureteral obstruction: comparison of KUL-7211, a selective β2/β3 agonist, with isoproterenol, terbutaline, and CL-316243.
Wanajo I; Tomiyama Y; Yamazaki Y; Kojima M
Urology; 2011 May; 77(5):1266.e1-6. PubMed ID: 21397304
[TBL] [Abstract][Full Text] [Related]
3. Modification of ureteral motility and promotion of urine flow around an intraureteral obstruction by CL-316243, phenylephrine, and furosemide in dogs.
Tomiyama Y; Murakami M; Akiyama K; Kojima M; Akahane M; Park YC; Kurita T
Neurourol Urodyn; 2002; 21(3):251-7. PubMed ID: 11948718
[TBL] [Abstract][Full Text] [Related]
4. Effects of isoproterenol and butylscopolamine on the friction between an artificial stone and the intraureteral wall in anesthetized rabbits.
Miyatake R; Tomiyama Y; Murakami M; Park YC; Kurita T
J Urol; 2001 Sep; 166(3):1083-7. PubMed ID: 11490303
[TBL] [Abstract][Full Text] [Related]
5. Role of the beta(3)-adrenoceptor in urine storage in the rat: comparison between the selective beta(3)-adrenoceptor agonist, CL316, 243, and various smooth muscle relaxants.
Takeda H; Yamazaki Y; Akahane M; Igawa Y; Ajisawa Y; Nishizawa O
J Pharmacol Exp Ther; 2000 Jun; 293(3):939-45. PubMed ID: 10869395
[TBL] [Abstract][Full Text] [Related]
6. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc JL
J Pharmacol Exp Ther; 1994 Mar; 268(3):1444-51. PubMed ID: 7908057
[TBL] [Abstract][Full Text] [Related]
7. Effects of beta(3)-adrenoceptor stimulation on prostaglandin E(2)-induced bladder hyperactivity and on the cardiovascular system in conscious rats.
Takeda H; Yamazaki Y; Igawa Y; Kaidoh K; Akahane S; Miyata H; Nishizawa O; Akahane M; Andersson KE
Neurourol Urodyn; 2002; 21(6):558-65. PubMed ID: 12382247
[TBL] [Abstract][Full Text] [Related]
8. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
[TBL] [Abstract][Full Text] [Related]
9. The effect of nitric oxide on the pressure of the acutely obstructed ureter.
Xingyu Y; Guoliang T; Youmei C; Honggen W; Yihong G; Junyi C
Urol Res; 2012 Apr; 40(2):163-9. PubMed ID: 21695424
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of beta3-adrenoceptor agonist in lower esophageal sphincter smooth muscle: in vitro studies.
Sarma DN; Banwait K; Basak A; DiMarino AJ; Rattan S
J Pharmacol Exp Ther; 2003 Jan; 304(1):48-55. PubMed ID: 12490574
[TBL] [Abstract][Full Text] [Related]
11. An effect of extrarenal beta adrenergic stimulation on the release of renin.
Reid IA; Schrier RW; Earley LE
J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
[TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide in beta3-adrenoceptor activation on basal tone of internal anal sphincter.
Banwait KS; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G547-55. PubMed ID: 12736154
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and coronary vasodilative properties of a selective and full beta 1-adrenoceptor agonist, T-0509, in comparison with isoproterenol in anesthesized dogs.
Yamazaki J; Sugimoto T; Yabana H; Nagao T
J Cardiovasc Pharmacol; 1994 Aug; 24(2):209-15. PubMed ID: 7526052
[TBL] [Abstract][Full Text] [Related]
15. Effects of cholinergic drugs on ureteral function in anesthetized dogs.
Tomiyama Y; Wanajo I; Yamazaki Y; Kojima M; Shibata N
J Urol; 2004 Oct; 172(4 Pt 1):1520-3. PubMed ID: 15371883
[TBL] [Abstract][Full Text] [Related]
16. Local and systemic effects of endoluminal pelvic perfusion of isoproterenol: a dose response investigation in pigs.
Jakobsen JS; Holst U; Jakobsen P; Steen W; Mortensen J
J Urol; 2007 May; 177(5):1934-8. PubMed ID: 17437851
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of beta-adrenoceptor subtypes mediating relaxation in porcine isolated ureteral smooth muscle.
Wanajo I; Tomiyama Y; Yamazaki Y; Kojima M; Shibata N
J Urol; 2004 Sep; 172(3):1155-9. PubMed ID: 15311061
[TBL] [Abstract][Full Text] [Related]
18. Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs.
Shen YT; Cervoni P; Claus T; Vatner SF
J Pharmacol Exp Ther; 1996 Sep; 278(3):1435-43. PubMed ID: 8819531
[TBL] [Abstract][Full Text] [Related]
19. Effects of coronary blood flow, myocardial contractility, and heart rate on cardiac lymph circulation in open-chest dogs. Use of a direct cannulation method for subepicardial lymph vessel.
Saito D; Hasui M; Shiraki T; Kono H
Arzneimittelforschung; 1997 Feb; 47(2):119-24. PubMed ID: 9079229
[TBL] [Abstract][Full Text] [Related]
20. The potency of KUL-7211, a selective ureteral relaxant, in isolated canine ureter: comparison with various spasmolytics.
Wanajo I; Tomiyama Y; Tadachi M; Kobayashi M; Yamazaki Y; Kojima M; Shibata N
Urol Res; 2005 Dec; 33(6):409-14. PubMed ID: 16133579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
